Alexandre-Franco M, Kouider R, Kassir Al-Karany R, Cuerda-Correa E, Al-Kassir A
Micromachines (Basel). 2024; 15(9).
PMID: 39337797
PMC: 11433824.
DOI: 10.3390/mi15091137.
Christfort J, Ortis M, Nguyen H, Marsault R, Doglio A
Biosensors (Basel). 2024; 14(8).
PMID: 39194630
PMC: 11352947.
DOI: 10.3390/bios14080401.
Large D, Soucy J, Hebert J, Auguste D
Adv Ther (Weinh). 2024; 2(1).
PMID: 38699509
PMC: 11064891.
DOI: 10.1002/adtp.201800091.
Fayazbakhsh F, Hataminia F, Mobaleghol Eslam H, Ajoudanian M, Kharrazi S, Sharifi K
Sci Rep. 2023; 13(1):21344.
PMID: 38049439
PMC: 10696074.
DOI: 10.1038/s41598-023-47291-6.
Xie R, Pal V, Yu Y, Lu X, Gao M, Liang S
Biomaterials. 2023; 304:122408.
PMID: 38041911
PMC: 10843844.
DOI: 10.1016/j.biomaterials.2023.122408.
Biocompatible High-Resolution 3D-Printed Microfluidic Devices: Integrated Cell Chemotaxis Demonstration.
Boaks M, Roper C, Viglione M, Hooper K, Woolley A, Christensen K
Micromachines (Basel). 2023; 14(8).
PMID: 37630125
PMC: 10456398.
DOI: 10.3390/mi14081589.
Construction of Bone Hypoxic Microenvironment Based on Bone-on-a-Chip Platforms.
Li C, Zhao R, Yang H, Ren L
Int J Mol Sci. 2023; 24(8).
PMID: 37108162
PMC: 10139217.
DOI: 10.3390/ijms24086999.
Development of 3D-Bioprinted Colitis-Mimicking Model to Assess Epithelial Barrier Function Using Albumin Nano-Encapsulated Anti-Inflammatory Drugs.
Almutary A, Alnuqaydan A, Almatroodi S, Bakshi H, Chellappan D, Tambuwala M
Biomimetics (Basel). 2023; 8(1).
PMID: 36810372
PMC: 9944493.
DOI: 10.3390/biomimetics8010041.
Scalable large-area mesh-structured microfluidic gradient generator for drug testing applications.
Yadav S, Tawade P, Bachal K, Rakshe M, Pundlik Y, Gandhi P
Biomicrofluidics. 2022; 16(6):064103.
PMID: 36483022
PMC: 9726219.
DOI: 10.1063/5.0126616.
Hydrogel-based microfluidic device with multiplexed 3D in vitro cell culture.
Clancy A, Chen D, Bruns J, Nadella J, Stealey S, Zhang Y
Sci Rep. 2022; 12(1):17781.
PMID: 36273031
PMC: 9588086.
DOI: 10.1038/s41598-022-22439-y.
Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies.
Ramamurthy R, Atala A, Porada C, Almeida-Porada G
Front Immunol. 2022; 13:1011143.
PMID: 36225917
PMC: 9549755.
DOI: 10.3389/fimmu.2022.1011143.
High-glucose 3D INS-1 cell model combined with a microfluidic circular concentration gradient generator for high throughput screening of drugs against type 2 diabetes.
Luo Y, Zhang X, Li Y, Deng J, Li X, Qu Y
RSC Adv. 2022; 8(45):25409-25416.
PMID: 35539797
PMC: 9082620.
DOI: 10.1039/c8ra04040k.
A Unidirectional 96-Well Fluidic Culture Platform for Upstream Cell Dosing with Subsequent Downstream Nonlinear and Ascending Exposure Gradients for Real-Time and Cell-Based Toxicity Screening Environments.
John B, Sloan D, Jensen T, Ramaiahgari S, End P, Resh G
Appl In Vitro Toxicol. 2022; 7(4):175-191.
PMID: 35028338
PMC: 8743950.
DOI: 10.1089/aivt.2021.0006.
Gravity-Based Flow Efficient Perfusion Culture System for Spheroids Mimicking Liver Inflammation.
Kim Y, Asif A, Salih A, Lee J, Hyun K, Choi K
Biomedicines. 2021; 9(10).
PMID: 34680487
PMC: 8533112.
DOI: 10.3390/biomedicines9101369.
Trends in the development of human stem cell-based non-animal drug testing models.
Lee S, Lee H
Korean J Physiol Pharmacol. 2020; 24(6):441-452.
PMID: 33093266
PMC: 7585597.
DOI: 10.4196/kjpp.2020.24.6.441.
Establishing a sensitive fluorescence-based quantification method for cyclic nucleotides.
Gruteser N, Kohlhas V, Balfanz S, Franzen A, Gunther A, Offenhausser A
BMC Biotechnol. 2020; 20(1):47.
PMID: 32854679
PMC: 7450941.
DOI: 10.1186/s12896-020-00633-y.
Micro Versus Macro - The Effect of Environmental Confinement on Cellular Nanoparticle Uptake.
Damle V, Sharmin R, Morita A, Nie L, Schirhagl R
Front Bioeng Biotechnol. 2020; 8:869.
PMID: 32793585
PMC: 7393206.
DOI: 10.3389/fbioe.2020.00869.
Reconfigurable Microphysiological Systems for Modeling Innervation and Multitissue Interactions.
Soucy J, Bindas A, Brady R, Torregrosa T, Denoncourt C, Hosic S
Adv Biosyst. 2020; 4(9):e2000133.
PMID: 32755004
PMC: 8136149.
DOI: 10.1002/adbi.202000133.
Microfluidic techniques for separation of bacterial cells via taxis.
Gurung J, Gel M, Baker M
Microb Cell. 2020; 7(3):66-79.
PMID: 32161767
PMC: 7052948.
DOI: 10.15698/mic2020.03.710.
CRISPR/Cas9-mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in -mutated breast cancer cells.
Mintz R, Lao Y, Chi C, He S, Li M, Quek C
Bioeng Transl Med. 2020; 5(1):e10152.
PMID: 31989039
PMC: 6971465.
DOI: 10.1002/btm2.10152.